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Evaluation of ﬂuoropyruvate as nucleophile in
reactions catalysed by N-acetyl neuraminic acid
lyase variants: scope, limitations and
stereoselectivity†
Jennifer Stockwell,a,b Adam D. Daniels,b,c Claire L. Windle,b,c Thomas A. Harman,a,b
Thomas Woodhall,a,b Tomas Lebl,d Chi H. Trinh,b,c Keith Mulholland,e
Arwen R. Pearson,‡b,c Alan Berry*b,c and Adam Nelson*a,b
The catalysis of reactions involving ﬂuoropyruvate as donor by N-acetyl neuraminic acid lyase (NAL)
variants was investigated. Under kinetic control, the wild-type enzyme catalysed the reaction between
ﬂuoropyruvate and N-acetyl mannosamine to give a 90 : 10 ratio of the (3R,4R)- and (3S,4R)-conﬁgured
products; after extended reaction times, equilibration occurred to give a 30 : 70 mixture of these products.
The eﬃciency and stereoselectivity of reactions of a range of substrates catalysed by the E192N, E192N/
T167V/S208V and E192N/T167G NAL variants were also studied. Using ﬂuoropyruvate and (2R,3S)- or
(2S,3R)-2,3-dihydroxy-4-oxo-N,N-dipropylbutanamide as substrates, it was possible to obtain three of
the four possible diastereomeric products; for each product, the ratio of anomeric and pyranose/furanose
forms was determined. The crystal structure of S. aureus NAL in complex with ﬂuoropyruvate was deter-
mined, assisting rationalisation of the stereochemical outcome of C–C bond formation.
Introduction
The introduction of fluorine can have a profound eﬀect on bio-
active molecules including their conformation, binding, bio-
availability, metabolism, pharmacokinetics and pharmaco-
dynamics.1 As a consequence, around 20% of prescribed
drugs, and 30% of leading blockbuster drugs, contain at least
one fluorine atom.2 Examples of fluorinated pharmaceuticals
include the cholesterol-lowering drug Atorvastatin, and
Sofosbuvir which is exploited in the treatment of Hepatitis C
(Fig. 1).3,4 Moreover, fluorinated sugars can serve as valuable
mechanism-based probes of carbohydrate-processing
enzymes.5
The stereoselective synthesis of compounds with a fluorine-
bearing stereocentre is a significant challenge. Most solutions
to this problem rely on stereoselective C–F bond formation,
for example by fluorination of allylic silanes.6 Some catalytic
methods for enantioselective C–F bond formation have been
developed: for example by organocatalytic α-fluorination
of aldehydes7 or Pd-catalysed α-fluorination of β-keto
phosphonates.8
Fig. 1 Examples of ﬂuorinated drugs.
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We envisaged a complementary catalytic approach in which
a F-bearing stereocentre would be controlled by formation of a
neighbouring C–C bond (Scheme 1). Aldolase-catalysed
reaction involving fluoropyruvate and an aldehyde 1 would
yield an aldol product 2 with two new stereogenic centres. This
catalytic approach would complement enantioselective aldol
reactions involving fluoroacetone.9
N-Acetyl neuraminic acid lyase (NAL) is a Class I aldolase
that catalyses the reversible aldol reaction between pyruvate
and N-acetyl mannosamine (ManNAc) to give N-acetyl neura-
minic acid (Neu5Ac). A combination of mutagenesis, structural
biology and computational chemistry has revealed insights
into its catalytic mechanism.10 Despite a report that it is not
a substrate,11 fluoropyruvate is a viable donor.12 However,
diﬀering stereochemical outcomes have been reported for the
NAL-catalysed reaction between fluoropyruvate and ManNAc.12
An initial aim of our study was, therefore, to clarify the stereo-
chemical outcome of this reaction.
We also sought to investigate the catalysed reactions
between fluoropyruvate and alternative aldehyde acceptors.
Here, we investigated the value of synthetically-useful NAL var-
iants that we have previously generated using directed evol-
ution.13,14 The E192N variant of NAL is an excellent catalyst of
the poorly stereoselective reaction between pyruvate and the
alternative substrate (2R,3S)-2,3-dihydroxy-4-oxo-N,N-dipropyl-
butanamide, DHOB (Scheme 2).13 The structural basis of the
modified substrate specificity of this variant has been gleaned
using protein crystallography.15 In contrast, the E192N/T167G
and E192N/T167V/S208V variants of NAL control the stereo-
chemistry of C–C bond formation, and catalyse respectively the
selective formation of the alternative diastereomeric products
3a and 3b (Scheme 2).14
Results and discussion
Evaluation of wild-type NAL in the synthesis of fluorinated
analogues of N-acetyl neuraminic acid
Initially, the reaction between fluoropyruvate and ManNAc cat-
alysed by wild-type NAL was investigated (Panel A, Scheme 3).
Accordingly, the reaction was performed at 37 °C in an NMR
tube (20 mM sodium fluoropyruvate and 100 mM N-acetyl
mannosamine in 20 mM Tris-HCl pH 7.4 buﬀer) and followed
by 19F NMR spectroscopy. After 500 min, the fluoropyruvate
was >98% consumed, and a 90 : 10 mixture of the diastereo-
meric products 4a and 4d had been formed (which vary only in
their configuration at C-3). However, after a prolonged reaction
time (∼5 weeks), with regular addition of more enzyme, the
ratio of products had switched to 30 : 70 in favour of 4d. The
alternative possible diastereomeric products (4b and 4c; Panel
B) were not detected. These data suggest that 4a is the kinetic
Scheme 1 Envisaged strategy for controlling F-bearing stereocentres
by C–C bond formation.
Scheme 2 Stereoselective aldol reactions catalysed by aldolases gen-
erated by directed evolution.14 The products are drawn in open chain
form for clarity.
Scheme 3 Reaction between ﬂuoropyruvate and ManNAc catalysed by
wild-type NAL. A: The stereochemical outcome is determined by the
reaction time. The products are depicted in open chain form for clarity.
NAL was regularly added to the 5 week reaction. B: Diastereomeric pro-
ducts that were not observed. C: Cyclised forms of 4a and 4d.
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product of the reaction, and that 4d is the thermodynamic
product. The relative thermodynamic stability of 4d may stem
from the stabilising gauche interaction between fluorine and
vicinal electronegative atoms.16 As with previous studies, the
reaction was found to yield selectively (4R)-configured pro-
ducts. The diﬀerent ratios of products under kinetic and ther-
modynamic control may account for the contrasting
selectivities reported in previous studies.12
The interpretation of the spectroscopic data was greatly
assisted by the preparation of standard samples of the pro-
ducts 4a and 4d.12a The reaction between ManNAc and
sodium fluoropyruvate, catalysed by wild-type NAL, was con-
ducted at 37 °C in 100 mM Tris-HCl pH 7.4 buﬀer, and the
products purified by column chromatography. After 24 h reac-
tion, the product 4a was obtained in 34% yield; whilst after
reaction for >1 week, the product 4d was obtained in 43%
yield. In both cases, a single pyranose anomer predominated
(Table 1; Panel C, Scheme 3). The configuration of 4a and 4d
was determined by careful analysis of vicinal coupling con-
stants.17 In both pyranose anomers of 4a, there was a large
coupling constant between fluorine and H-4 (∼30 Hz) and a
small coupling constant between H-3 and H-4 (2.1 Hz in the
major anomer) (Table 1). In contrast, in the major anomer of
4d, there was a small coupling constant between fluorine and
H-4 (∼12 Hz) and a large coupling constant between H-3 and
H-4 (8.8 Hz).
The catalysis of the cleavage of the reaction products 4a
and 4d was also studied using an established coupled enzyme
assay13b (Table 2). The cleavage of the fluorinated N-acetyl
neuraminic acid analogue 4a was much less eﬃcient than that
of Neu5Ac itself (kcat/KM: 0.11 min
−1 mM−1 for 4a compared
with 260 min−1 mM−1 for Neu5Ac). However, the catalysis of
the cleavage of the diastereomeric fluorinated analogue 4d was
even less eﬃcient and was not detectable under the conditions
of the assay. This observation is consistent with (3R,4R)-config-
ured 4a being the kinetic product of the NAL-catalysed reaction
between fluoropyruvate and ManNAc.
Preparation of substrate precursors
To enable evaluation of alternative potential substrates,
a range of alkene precursors was prepared: ozonolysis of these
alkenes (10, ent-10, 15 and ent-15) would yield the corres-
ponding aldehydes (DHOB, ent-DHOB, AHOB§ and ent-AHOB).
The alkene13a ent-10 was prepared using a route that was ana-
logous to an established18 synthesis of 10 (Scheme 4). Thus,
treatment of the lactone 5 (derived from lyxose19) with concen-
trated hydrochloric acid in acetone gave the corresponding
acetonide20 6. Treatment of 6 with iodine and triphenyl-
phosphine gave the corresponding iodolactone 7, which was
followed by reductive ring-opening to give the carboxylic acid
ent-8 (whose enantiomer had been used to prepare18 10).
Finally, amide formation (→9) and deprotection gave the
required alkene ent-10.
The alkenes 15 and ent-15 were prepared from the known21
enantiomerically pure lactones 11 and ent-11 (see Scheme 4 for
the synthesis of 15). Treatment of the lactone 11 with LHMDS
at −78 °C, and reaction with the N-sulfonyl imine 12, gave the
product 13 as a 94 : 6 mixture of diastereomers; the relative
configuration of the major diastereomer was determined by
subsequent conversion into a cyclic derivative (see below). The
lactone 13 was ring-opened by treatment with Pr2NAlMe2 and,
Table 2 Kinetic parameters for the cleavage of substrates catalysed by
wild-type NALa
Substrate kcat/min
−1 KM/mM kcat/KM/min
−1 mM−1
Neu5Ac 510 ± 10 2.0 ± 0.1 260
4a 0.91 ± 0.03 8.4 ± 0.7 0.11
4b NDb NDb
aDetermined using a coupled enzyme assay involving lactate
dehydrogenase. bNot detectable.
Table 1 Spectroscopic data for the ﬂuorinated products of aldolase-catalysed reactions
Product Form (proportion)
δF/
ppm
δ3H/
ppm
δ4H/
ppm
δ5H/
ppm
δ6H/
ppm
2JHF
a/
Hz
3JHF
a/
Hz
3J3H–4H/
Hz
3J4H–5H/
Hz
3J5H–6H/
Hz
4a Major pyranose (98%) −208.1 4.65 3.93 4.07 3.87 49.3 30.0 2.1 10.6 10.6
Minor pyranose (2%) −217.9 NMb NMb NMb NMb 51.3 29.9 NMb NMb NMb
4d Major pyranose (96%) −199.3 4.47 ∼3.90 ∼3.90 ∼3.90 49.7 12.0 8.8 NMb NMb
16a Major pyranose (92%) −206.0 4.78 3.94 3.88 4.75 49.9 32.5 3.4 9.7 9.2
Minor pyranose (8%) −216.8 NMb NMb NMb NMb 51.4 32.8 NMb NMb NMb
16c Major pyranose (35%) −190.5 4.85 4.39 4.12 4.65 50.5 24.0 4.8 5.0 6.1
Major furanose (25%) −194.5 4.72 4.02 3.96 NMb 43.7 4.7 1.7 NMb NMb
Minor pyranose (30%) −201.9 5.03 4.46 3.95 4.57 53.1 18.7 5.5 5.6 7.2
Minor furanose (10%) −207.4 4.86 4.30 4.18 4.75 48.5 10.1 7.3 NMb 5.4
ent-16d Pyranose (>98%) −199.8 4.60 3.95 3.78 4.62 49.3 13.3 9.3 9.3 9.7
17a Major pyranose (98%) −207.8 4.90 4.16 4.23 4.83 49.0 29.1 2.2 10.9 10.0
Minor pyranose (2%) −218.5 NMb NMb NMb NMb 50.2 28.8 NMb NMb NMb
aDetermined by analysis of the 296 MHz 19F NMR spectrum. bNot measured.
§ (2R,3S)-3-acetyl-2-hydroxy-4-oxo-N,N-dipropylbutanamide.
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following acetal hydrolysis, the β-amino amide derivative 14
was obtained in 88% yield. Finally, desulfonylation of 14, fol-
lowed by acetylation, gave the required alkene 15.
Evaluation of variant NALs in the catalysis of reactions
involving fluoropyruvate
Eﬃciency of catalysis. The ability of NAL variants to catalyse
reactions involving fluoropyruvate as donor was investigated.
The aldehydes DHOB, ent-DHOB, AHOB and ent-AHOH were
investigated as potential substrates for the E192N, E192N/
T167G and E192N/T167V/S208 V NAL variants (Scheme 5). The
eﬃciency of catalysis was initially investigated by determining
the rate of consumption of fluoropyruvate by 19F NMR
spectroscopy. In each case, the corresponding alkene precursor
(10, ent-10, 15 or ent-16) was cleaved ozonolytically in methanol
at −78 °C, and the reaction mixture quenched with dimethyl-
sulfide, transferred into an NMR tube and evaporated; the
reaction (20 mM sodium fluoropyruvate and 100 mM substrate
in 50 mM Tris-HClpH 7.4 buﬀer) to give aldol products was
then followed by 296 MHz 19F NMR spectroscopy. The results
are presented in Table 3.
The rate of consumption of fluoropyruvate was highest with
the combination of DHOB and the E192N variant (9.1 nmol
min−1 per nmol protein). This observation is, perhaps, unsur-
prising given that E192N was obtained via a directed evolution
approach that sought to optimise catalysis of cleavage to yield
DHOB.13 However, it is notable that the E192N variant – in
addition to the wild-type enzyme – accepts fluoropyruvate as
an alternative donor.
Scheme 4 Synthesis of precursors of aldehyde substrates. In addition,
the alkene ent-15 was prepared from the enantiomeric lactone starting
material 11; and 10 was prepared using an established route.16
Scheme 5 Possible diastereomeric products of aldolase-catalysed
reactions with ﬂuoropyruvate as nucleophile.
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Catalysis by the E192N variant was significantly less
eﬃcient with the other substrates investigated. For example,
with AHOB, in which the α-hydroxy group of DHOB has been
replaced with an α-NHAc group, the rate of consumption of
fluropyruvate was about 8-fold slower. Switching to the enan-
tiomeric substrate series was also detrimental to catalysis: the
rate of consumption of fluoropyruvate was about 20-fold
slower with ent-DHOB (compared to DHOB) and about 15-fold
slower with ent-AHOB (compared to AHOB).
In addition, the E192N/T167G and E192N/T167V/S208V var-
iants are less eﬃcient catalysts than the E192N variant. For
example, with DHOB as substrate, the rate of consumption of
fluoropyruvate was about 15- and 150-fold slower with the
E192N/T167G and E192N/T167V/S208V variants respectively
than with the E192N variant. These variants were generated to
catalyse complementary stereoselective reactions between pyru-
vate and DHOB (Scheme 2): a reduction in the eﬃciency of cat-
alysis (compared to the E192N variant) was also observed with
pyruvate as the donor substrate.14
Preparation and characterisation of reaction products
The determination of the stereoselectivity of the reactions was
complicated by the possibility of four diastereomeric products,
each of which might exist in diﬀerent anomeric and pyranose/
furanose forms. To assist analysis, selected reactions were con-
ducted preparatively, and the products purified and character-
ised (Table 4). In each case, the aldehyde substrate and
sodium fluoropyruvate were dissolved in 50 mM Tris-HCl pH
7.4 buﬀer, and the relevant NAL variant added. The conversion
of each reaction was determined by analysis of the crude
product by 296 MHz 19F NMR spectroscopy.
In two cases, the aldolase-catalysed reactions were highly
diastereoselective, and >98 : <2 mixtures of diastereomeric pro-
ducts were obtained after ion exchange chromatography. Thus,
with the E192N/T167V/S208V variant, fluoropyruvate and
DHOB reacted to give 16c which was isolated in 41% yield.
Similarly, with the same NAL variant, fluoropyruvate and ent-
DHOB reacted to give ent-16d which was isolated in 52% yield.
However, with the E192N variant, fluoropyruvate and DHOB
were converted into a 40 : 60 mixture of 16a and 16c from
which it was possible to obtain small samples of both products
after reverse-phase HPLC purification. Similarly, using E192N,
fluoropyruvate and AHOB reacted to give a diastereomeric
mixture of products, from which a small sample of 17a could
be obtained by mass-directed HPLC.
The fluorinated products 16a, ent-16d and 17a existed in
pyranose forms (Panel A, Fig. 2). In both pyranose anomers of
16a and 17a, there was a large coupling constant between fluo-
rine and H-4 (∼30 Hz); in addition, in the major anomer of
each compound, there was a small coupling constant between
H-3 and H4 (16a: 3.4 Hz; 17a: 2.2 Hz) (Table 3). These data
imply that 16a and 17a are (3R,4R)-configured (and indirectly
enabled determination of the relative configuration of 13). In
contrast, ent-16d had a small coupling constant between the
Table 4 Preparation of ﬂuorinated products of aldolase-catalysed
reactions
Substratea
(eq.) Variant Productb
Time/day
(conversionc/
%)
Yieldd/%
(ratioe)
DHOB
(2 eq.)
E192N 16a and
16c
2 (>99) 33 f (40 : 60)
DHOB
(2 eq.)
E192N/T167
V/S208V
16c 2 (95) 41
ent-DHOB
(1 eq.)
E192N/T167
V/S208V
ent-16d 1 (NMg) 52
AHOB (5 eq.) E192N 17a 5 (50) 7h
a Prepared by ozonolysis of the corresponding alkene (10, ent-10, 15 or
ent-15). b See Table 1 for details of ratios of anomers and pyranose/
furanose forms. cDetermined by analysis of the crude product by
296 MHz 19F NMR spectroscopy. d Yield of purified product based on
the limiting reactant. eDetermined by 296 MHz 19F NMR spectroscopy.
f Small samples of each diastereomer could be obtained by reverse-
phase HPLC. gNot measured. h After purification by mass-directed
HPLC.
Table 3 Activity and selectivity of aldolase variants with ﬂuoropyruvate as donor
Substratea Variant Specific activityb/nmol min−1 nmol−1 Product Ratioc a : b : c : d (3R,4R) : (3S,4S) : (3R,4S) : (3S,4R)c
DHOB E192N 9.1 16 40 : 0 : 50 : 10 40 : 0 : 50 : 10
DHOB E192N/T167V/S208V 0.56 16 0 : 0 : 100 : 0 0 : 0 : 100 : 0
DHOB E192N/T167G 0.06 16 30 : 0 : 70 : 0 30 : 0 : 70 : 0
ent-DHOB E192N 0.46 ent-16 10 : 0 : 0 : 90 0 : 10 : 90 : 0
ent-DHOB E192N/T167V/S208V 0.03 ent-16 0 : 0 : 0 : 100 0 : 0 : 100 : 0
ent-DHOB E192N/T167G 0.12 ent-16 20 : 0 : 0 : 80 0 : 20 : 80 : 0
AHOB E192N 1.1 17 60 : 0 : 40 : 0 60 : 0 : 40 : 0
AHOB E192N/T167V/S208V NDe —
AHOB E192N/T167G 0.03 17 NMd
ent-AHOB E192N 0.07 ent-17 NMd
ent-AHOB E192N/T167V/S208V NDe —
ent-AHOB E192N/T167G 0.03 ent-17 NMd
a Prepared by ozonolysis of the corresponding alkene (10, ent-10, 15 or ent-15). b Consumption of fluoropyruvate (nmol min−1 per nmol protein)
determined by 296 MHz 19F NMR spectroscopy. c Kinetic ratio of diastereomeric products determined by 296 MHz 19F NMR spectroscopy. dNot
measured. eNot detectable.
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equatorially-positioned fluorine and H-4 (13.3 Hz) and a large
coupling constant between the axial protons H-3 and H-4
(9.3 Hz). The configuration of 16a and ent-16d was corrobo-
rated by the observation of nOe interactions between the axial
protons at H-4 and H-6. The analysis of 16c was hugely compli-
cated by the existence of both pyranose and furanose anomers
(Panel B, Fig. 2); however, 1H/19F HSQC-TOCSY spectroscopy
enabled extraction of the 1H NMR spectra of each of the four
species that were present (Table 1 and ESI†). The pyranose
anomers of 16c have axially-oriented fluorine and 4-OH groups
which cannot enjoy a stabilising gauche interaction.16
Stereoselectivity of reactions. The characterisation of the
products enabled determination of the stereoselectivity of
reactions catalysed by NAL variants (Table 3). With the
E192N variant, DHOB and fluoropyruvate yielded a
40 : 0 : 50 : 10 mixture of 16a, 16b, 16c and 16d; this poor
stereoselectivity parallels that observed with this enzyme in the
reaction between pyruvate and DHOB.13a,14 In contrast, the
E192N/T167V/S208V variant yielded selectively the (3R,4S)-con-
figured product 16c. This variant was generated14 by directed
evolution to yield selectively the 4S-configured product (3b)
with pyruvate as nucleophile (Scheme 2): it is remarkable that
the 4S selectivity is retained with an alternative nucleophile
(fluoropyruvate). However, in contrast, selectivity for 4R-config-
ured products was not observed with the E192N/T167G
variant: with this variant, the reaction between DHOB and
fluoropyruvate was very ineﬃcient, and a 30 : 70 mixture of 16a
and 16c was obtained.
The eﬀect of the structure of the aldehyde substrate on
stereoselectivity was also investigated. AHOB has an α-NHAc
group in place of the α-hydroxy group of DHOB; with AHOB
and the E192N variant, similarly poor stereoselectivity was also
observed with this substrate (17a : 17b : 17c : 17d 60 : 0 : 40 : 0).
In the enantiomeric series, ent-DHOB gave predominantly the
(3R,4S)-configured product ent-16d with all three NAL variants;
here, the NAL variant had only a small eﬀect on the stereo-
selectivity of the aldol reaction.
Structural insights into stereoselectivity. It is notable that
all combinations of substrates and NAL variants yielded
Fig. 2 Forms of reaction products. Panel A: The products 16a, ent-16d
and 17a exist predominantly in pyranose forms. Panel B: the product 16c
exists as a mixture of pyranose and furanose anomers.
Fig. 3 Rationale for stereoselectivity of NAL-catalysed reactions
between ﬂuoropyruvate and aldehyde substrates. Panel A: S. aureus NAL
in complex with ﬂuoropyruvate with general acid Y137 and residues that
have key roles in recognition and stereocontrol (T167, E192 and S208)
shown (PDB: 5A8G). The top face (as depicted) of the Z-conﬁgured
enamine is poised to react with an aldehyde substrate. Panel B: Y137A
variant of E. coli NAL in compex with 4-epi-Neu5Ac (PDB: 4BWL). Panel
C: Possible stereochemical outcomes of the reaction of the top face of
the Z-conﬁgured enamine with an aldehyde substrate.
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3R-configured products selectively under kinetic control. With
DHOB/AHOB, the products 16a/17a [with (3R,4R) configur-
ation] and/or 16c/17c [with (3R,4S) configuration] pre-
dominated. With ent-DHOB, although a diﬀerent diastereomer
(ent-16d) was formed selectively, its absolute configuration was
still (3R,4S). In contrast, the stereoselectivity at C-4 could
sometimes be altered by changing the enzyme variant used.
To gain an insight into the structural basis of stereo-
selectivity, the crystal structure of S. aureus NAL was deter-
mined in complex with fluoropyruvate (PDB: 5A8G) (Panel A,
Fig. 3); the structure and kinetic properties of S. aureus NAL
have been previously shown to be extremely similar to those of
E. coli NAL.22 The formation of a Z-configured enamine was
observed, which presents only one face to aldehyde substrates.
Reaction of this face of the (Z)-enamine intermediate would
necessarily lead to the formation of 3R-configured products.
The structure10 of an aldol product (4-epi-Neu5Ac) in complex
with NAL (the Y137A variant of the E. coli enzyme) (PDB:
4BWL) is provided for comparison (Panel B, Fig. 3). Previous
studies have shown that an analogue of DHOB – (2R,3S)-2,3-tri-
hydroxy-4-oxo-N,N-dipropyl butanamide – can bind to the
E192N variant of E. coli NAL in two distinct conformations
(Panel B, Fig. 3).15 Aldehyde substrates may react via confor-
mations that allow protonation by the general acid Y137.10 The
facial selectivity of the reaction of the aldehyde determines the
configuration of the product – (3R,4R) or (3R,4S) – obtained
(Panel C, Fig. 3). In some cases, the ratio of C-4 epimers could
be changed by altering the specific NAL variant used.
Conclusions
NAL variants can be useful catalysts of reactions between fluoro-
pyruvate and aldehyde substrates. Wild-type NAL catalysed the
reaction between fluoropyruvate and ManNAc, albeit much
less eﬃciently than with pyruvate as donor. It was shown that
a 90 : 10 ratio of (3R,4R)- and (3S,4R)-configured products was
obtained under kinetic control; whilst a 30 : 70 mixture of
these products was obtained at equilibrium. The switch
between kinetic and thermodynamic control may account for
previous apparently conflicting reports of the outcome of this
reaction.12
It was also shown that NAL variants are useful catalysts of
reactions between fluoropyruvate and unnatural aldehyde sub-
strates. The eﬃciency of catalysis varied widely, depending on
the specific combination of NAL variant and aldehyde used.
However, using the aldehyde DHOB or its enantiomer as sub-
strate, three of the four possible diastereomeric products could
be isolated.
It was noted that, under kinetic control, all productive NAL
variant-catalysed reactions involving fluoropyruvate yielded
(3R)-configured products selectively. The crystal structure of
S. aureus NAL in complex with fluoropyruvate reveals the pres-
ence of a (Z)-configured enamine. The (3R)-selectivity of NAL
catalysed reactions may be rationalised in terms of selective
reaction of this (Z)-configured enamine via the face that is
presented to aldehyde substrates.
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